{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-013681","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2025-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.496502+00:00","generated_at":"2026-05-24T11:36:47.558578+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ChromaDex rebrands as Niagen Bioscience; Nasdaq ticker becomes NAGE","bullets":["Name change from ChromaDex Corporation to Niagen Bioscience, Inc. effective March 19, 2025.","Common stock begins trading under new ticker symbol 'NAGE' on Nasdaq; CUSIP unchanged.","Rebranding reflects focus on flagship Niagen ingredient and NAD+ healthy-aging science; no operational changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-013681","json":"https://secwatch.observer/filing/0001628280-25-013681.json","markdown":"https://secwatch.observer/filing/0001628280-25-013681.md","text":"https://secwatch.observer/filing/0001628280-25-013681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025013681/0001628280-25-013681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025013681/cdxc-20250317.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T11:36:47.558578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}